Helius Medical Technologies Inc (HSDT) is 24.22% away from 50-day simple Moving Average despite all headwinds

On Friday, Helius Medical Technologies Inc (NASDAQ: HSDT) trading session started at the price of On Friday, that was -13.56% drop from the session before settling in for the closing price of $0.81. A 52-week range for HSDT has been $0.37 – $9.50.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

A company in the Healthcare sector has jumped its sales by 33.74% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 61.26%. With a float of $3.68 million, this company’s outstanding shares have now reached $3.73 million.

In an organization with 22 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -6.18%, operating margin of -2590.04%, and the pretax margin is -1764.74%.

Helius Medical Technologies Inc (HSDT) Insider and Institutional Ownership

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Helius Medical Technologies Inc stocks. The insider ownership of Helius Medical Technologies Inc is 1.42%, while institutional ownership is 2.17%.

Helius Medical Technologies Inc (HSDT) Latest Financial update

According to the Wall Street analysts, stocks earnings will be around 61.26% per share during the next fiscal year.

Helius Medical Technologies Inc (NASDAQ: HSDT) Trading Performance Indicators

You can see what Helius Medical Technologies Inc (HSDT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.51.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.18, a number that is poised to hit -0.94 in the next quarter and is forecasted to reach -2.50 in one year’s time.

Technical Analysis of Helius Medical Technologies Inc (HSDT)

Let’s dig in a bit further. During the last 5-days, its volume was 25.72 million. That was better than the volume of 0.85 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 40.60%. Additionally, its Average True Range was 0.16.

During the past 100 days, Helius Medical Technologies Inc’s (HSDT) raw stochastic average was set at 30.38%, which indicates a significant increase from 26.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 303.58% in the past 14 days, which was higher than the 164.29% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.5637, while its 200-day Moving Average is $1.6274. However, in the short run, Helius Medical Technologies Inc’s stock first resistance to watch stands at $0.7899. Second resistance stands at $0.8795. The third major resistance level sits at $0.9495. If the price goes on to break the first support level at $0.6303, it is likely to go to the next support level at $0.5603. The third support level lies at $0.4707 if the price breaches the second support level.

Helius Medical Technologies Inc (NASDAQ: HSDT) Key Stats

There are 3,728K outstanding shares of the company, which has a market capitalization of 2.26 million. As of now, sales total 640 K while income totals -8,850 K. Its latest quarter income was 50 K while its last quarter net income were -3,690 K.